What is STREAM?

STREAM is a collaboration of researchers who share a common set of principles about the goals and methods for studying clinical translation. We apply empirical and philosophical tools for addressing scientific, ethical, and policy challenges in the development and translation of health technologies. Our members work in ethics, epidemiology, biology, psychology, and various medical specialties. The network is centered at McGill University, and has affiliates throughout North America and abroad.

Hiring at STREAM!

STREAM is inviting applications for a postdoctoral research fellow (PDF). The position requires a background a background in clinical trials or ethics. The project will examine how risk, benefit, burdens, and clinical hypotheses evolve as new drugs are developed- and whether there are ways to improve efficiencies in clinical development. The project will also apply forecast methods.

Postdoctoral Fellow in Biomedical Ethics & Meta-Research

News

Jonathan Kimmelman quoted in Retraction Watch, commenting on the retraction of the much-debated blockchain paper from F1000. Blog post forthcoming.

Jonathan Kimmelman quoted in La Presse, Daz, and CNN, following a publication with PhD student Carole Federico in Nature. The story has also been picked up STAT, Science Daily, and MSN

Dr. Kimmelman was also interviewed for CBC's Second Opinion

Jonathan Kimmelman quoted in MIT Technology Review

Jonathan Kimmelman gives his take on underreporting of adverse events in trial reports: Des effets secondaires des médicaments restent absents des publications scientifiques in Le Devoir

Jonathan Kimmelman quoted in the Portland Press Herald

Jonathan Kimmelman quoted in CMAJ

Jonathan Kimmelman's work for the new International Society for Stem Cell Research guidelines featured in Nature

Work of STREAM profiled in Nature Reviews Clinical Oncology

Our Latest Publications

Hakala A, Fergusson D, Kimmelman J. Nonpublication of trial results for new neurological drugs: A systematic review. Annals of Neurology, 2017.

Our Latest Publications

Kimmelman J, Resnik DB, Peppercorn J, Ratain MJ. Burdensome Research Procedures in Trials: Why Less is More. JNCI. 2017. DOI:https://doi.org/10.1093/jnci/djw315

Our Latest Publications

Mattina J, Carlisle B, Hachem Y, Fergusson D, Kimmelman J. Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review. PLOS Biology February 3, 2017.

Our Latest Publications

Kimmelman J. and Federico C. Consider drug efficacy before first-in-human trials. Nature January 30, 2017.

All content © STREAM research

admin@translationalethics.com
Twitter: @stream_research
3647 rue Peel
Montreal QC H3A 1X1